Figure 3
Overall survival during 5 years of follow-up in patients with ALL, according to the type of postinduction chemotherapy.

Overall survival during 5 years of follow-up in patients with ALL, according to the type of postinduction chemotherapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal